cerrar
Tagged with GE

The 3 T’s: Positioning Ireland for FDI
What makes Ireland attractive for FDI? As the former general manager of Genzyme‰Ûªs Waterford site, Pat O‰ÛªSullivan explains that a…

Ireland: Cut costs or add value?
It is widely acknowledged that pharmaceutical manufacturing operations have entered into a period of significant cost reduction. Service providers…

Interview: Stanley Chang Chairman and CEO, Medigen Biotechnology…
The chairman and CEO of Medigen shares his insights on a significant past three years for the company, which included both an IPO and major…

Interview with Fergal Murphy, Chairman, Association of…
Fergal Murphy, Chairman of the Association of Pharmaceutical Manufacturers in Ireland, discusses with pharamaboardroom.com the difficulties in such a…

Interview with Johan Ström Managing Director, Biogen Idec Sweden
Having experienced many years at big pharmaceutical companies, you moved into the biotech sector by joining Biogen Idec late 2010. What made you…

Interview with Eric NG President Director, Sanofi Group Indonesia
Eric Ng received his degree at National University of Singapore. In his career he has worked for such companies as AstraZeneca before moving to…

Spicing up The Mexican OTC Market
In the late 1990s, Rodrigo Herrera Aspra wanted to commercialize a new anti-acne formulation, and was advised by a friend who was involved in the…

Interview: Ray O’Neill, Managing Director, ESS Ltd
Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in…

Interview: Ray O'Neill, Managing Director, ESS Ltd
Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in…

Interview with Brenden Martin, General Manager, Genzyme –…
Mr. Martin, you were appointed as Genzyme’s GM for UK and Ireland last month after having spent a decade at the organization. Robin Kenselaar,…

Interview with Sabrina Suetens, General Manager at Cegedim CRM,…
October marks the completion of your first full year as general manager of Cegedim’s Belgian affiliate. To what extent do you feel that the…

Interview with Patrik De Haes, Chief Executive Officer,…
Dr De Haes, as the CEO of ThromboGenics for the last five years, can you provide us with an overview of the company’s main achievements that you are…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here